1 August 2018Americas

Amneal obtains non-infringement finding in Sensipar case

Generic drug maker Amneal has secured a finding of non-infringement in a Hatch-Waxman case over kidney disease drug Sensipar (cinacalcet hydrochloride).

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Court grants order to resolve Amgen v FDA paediatric dispute

6 June 2017 A district court has granted a stipulated order to the US Food and Drug Administration and Amgen, after they jointly asked the court to end a case centring on paediatric exclusivity for Sensipar.

Amgen sues Apotex over Sensipar generic

14 October 2016 Amgen has filed a complaint against Apotex for allegedly infringing a patent centring on Sensipar tablets.

Amgen takes on Emcure over Sensipar generic

10 September 2018 Amgen has accused India-based Emcure Pharmaceuticals of patent infringement, in a bid to protect its drug Sensipar.

More on this story

Court grants order to resolve Amgen v FDA paediatric dispute

6 June 2017 A district court has granted a stipulated order to the US Food and Drug Administration and Amgen, after they jointly asked the court to end a case centring on paediatric exclusivity for Sensipar.

Amgen sues Apotex over Sensipar generic

14 October 2016 Amgen has filed a complaint against Apotex for allegedly infringing a patent centring on Sensipar tablets.

Amgen takes on Emcure over Sensipar generic

10 September 2018 Amgen has accused India-based Emcure Pharmaceuticals of patent infringement, in a bid to protect its drug Sensipar.

More on this story

Court grants order to resolve Amgen v FDA paediatric dispute

6 June 2017 A district court has granted a stipulated order to the US Food and Drug Administration and Amgen, after they jointly asked the court to end a case centring on paediatric exclusivity for Sensipar.

Amgen sues Apotex over Sensipar generic

14 October 2016 Amgen has filed a complaint against Apotex for allegedly infringing a patent centring on Sensipar tablets.

Amgen takes on Emcure over Sensipar generic

10 September 2018 Amgen has accused India-based Emcure Pharmaceuticals of patent infringement, in a bid to protect its drug Sensipar.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent